(secondQuint)Refractory Status Epilepticus Treatment Study.

 Phase III Clinical trial, to identify the most effective dose of valproic acid (20mg/kg bolus, 1mg/kg/h maintenance vs 40mg/kg bolus, 2mg/kg/h maintenance) in combination with phenytoin, in patients with refractory status epilepticus.

 Multicenter clinical trial, single-blind, prospective, randomized 1:1 assignment.

.

 Refractory Status Epilepticus Treatment Study@highlight

Identify the most effective dose of valproic acid when used in combination with phenytoin for treatment of patients with refractory status epilepticus, which allow a better clinical course and prognosis of the disease.

